NCT07113132Not yet recruiting
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia
Source: ClinicalTrials.gov · Last updated 8 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
aim of the work 1. To evaluate the presence of SF3B1-K700E mutation in acute lymphoblastic leukemia and chronic lymphocytic leukemia. 2. To determine the correlation between the presence of SF3B1-K700E mutation with other laboratory findings.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 84 (estimated)
- First submitted
- 15 Jul 2025
- Start date
- 1 Aug 2025
- Primary completion date
- 1 Jul 2026
- Lead sponsor
- Safaa Ali
- NCT number
- NCT07113132
What you commit to
- Study type: Observational
- Planned participants: 84
- From 1 Aug 2025 to the primary completion date, 1 Jul 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with any other type of malignancies
Who the study is looking for
- Patients with acute lymphocytic leukemia or chronic lymphocytic leukemia of both genders at any age.
Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.